Pharmacokinetics of inhibitors of prostaglandin synthesis in the perinatal period.
D000293:Adolescent; D000328:Adult; D000375:Aging; D000818:Animals; D002648:Child; D002675:Child, Preschool; D016861:Cyclooxygenase Inhibitors; D005260:Female; D005333:Fetus / Q000378:metabolism; D006207:Half-Life; D006801:Humans; D007213:Indomethacin / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D007223:Infant; D007231:Infant, Newborn; D007700:Kinetics; D007743:Labor, Obstetric / Q000187:drug effects*; D008431:Maternal-Fetal Exchange; D010920:Placenta / Q000378:metabolism; D011247:Pregnancy; D011448:Prostaglandin Antagonists / Q000494:pharmacology*; D011453:Prostaglandins / Q000096:biosynthesis*; D012459:Salicylates / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D013045:Species Specificity
D016861:Cyclooxygenase Inhibitors; D011448:Prostaglandin Antagonists; D011453:Prostaglandins; D012459:Salicylates; D007213:Indomethacin